Answers are grounded in this paper and cite their sources.
Single-strain Bacillus subtilis TL-2 (T1) and composite B. subtilis TL-2 plus B. amyloliquefaciens TL-7 (T2) formulations were compared with a water control in a randomized field trial with three blocks. Disease index and rhizome yield were assessed during 2022–2024; microbiome, soil, agronomic, and quality measurements were restricted to 2024. T2 achieved 69.8% disease control efficacy, compared with 45.4% for T1, and increased fresh rhizome yield from 22.6 to 34.8 t ha–1. Both formulations improved several quality traits, with larger responses under T2. Treatment differences were reported at P < 0.05 or P < 0.01. Community and soil changes accompanied disease and crop responses, but these associations do not establish causal pathways. The findings support evaluating microbial formulations through disease control, yield, and rhizome quality together.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: